![](/img/cover-not-exists.png)
A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85
Jens Overgaard, Hanne Sand Hansen, Marie Overgaard, Lars Bastholt, Anne Berthelsen, Lena Specht, Birgit Lindeløv, Karsten JørgensenVolume:
46
Year:
1998
Language:
english
DOI:
10.1016/s0167-8140(97)00220-x
File:
PDF, 185 KB
english, 1998